Location History:
- Trooz, BE (2010 - 2011)
- Olne, BE (2014 - 2018)
Company Filing History:
4 out of 86 
1 out of 93 
1 out of 832,843 Years Active: 2010-2018
Title: Innovations of Didier Cataldo
Introduction
Didier Cataldo is a notable inventor based in Olne, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating pulmonary inflammatory diseases. With a total of five patents to his name, Cataldo's work showcases his dedication to advancing medical science.
Latest Patents
One of Didier Cataldo's latest patents is focused on cyclodextrin and budesonide derivative compositions and methods. This invention relates to novel pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and prevention of pulmonary inflammatory diseases. Additionally, it introduces a new analytical technique for detecting and quantifying HP-β-CD in solution. More specifically, it involves the use of validated 1H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without any extraction or separation steps for liquid formulations. Another significant patent involves the use of cyclodextrin for the treatment and prevention of bronchial inflammatory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD).
Career Highlights
Throughout his career, Didier Cataldo has worked with prestigious institutions, including the University of Liège and Université Libre de Bruxelles. His research and innovations have had a profound impact on the pharmaceutical industry, particularly in the area of respiratory diseases.
Collaborations
Didier Cataldo has collaborated with notable colleagues such as Brigitte Evrard and Jean-Michel Foidart. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Didier Cataldo's innovative work in pharmaceuticals, particularly in the treatment of pulmonary inflammatory diseases, highlights his significant contributions to medical science. His patents reflect a commitment to improving health outcomes through advanced pharmaceutical formulations.